Andrew W. Thomas

5.7k total citations · 3 hit papers
44 papers, 4.9k citations indexed

About

Andrew W. Thomas is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Andrew W. Thomas has authored 44 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 20 papers in Organic Chemistry and 14 papers in Cellular and Molecular Neuroscience. Recurrent topics in Andrew W. Thomas's work include Neuroscience and Neuropharmacology Research (10 papers), Receptor Mechanisms and Signaling (9 papers) and Chemical Synthesis and Analysis (6 papers). Andrew W. Thomas is often cited by papers focused on Neuroscience and Neuropharmacology Research (10 papers), Receptor Mechanisms and Signaling (9 papers) and Chemical Synthesis and Analysis (6 papers). Andrew W. Thomas collaborates with scholars based in Switzerland, United Kingdom and United States. Andrew W. Thomas's co-authors include Steven V. Ley, David C. Rees, David M. Wilson, Ian Churcher, Luis C. Misal Castro, Anthony Wood, David C. Blakemore, Frédéric Knoflach, Harry Finch and Maria‐Clemencia Hernandez and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Neuroscience and Chemical Communications.

In The Last Decade

Andrew W. Thomas

44 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Modern Synthetic Methods for Copper‐Mediated C(aryl)O, C(aryl)N, and C(aryl)S Bond Formation

2004 2.0k citations Steven V. Ley, Andrew W. Thomas profile →
Organic synthesis provides opportunities to transform drug discovery

2018 1.2k citations Andrew W. Thomas et al. profile →
Moderne Synthesemethoden: Kupfer‐vermittelte C(Aryl)‐O‐, C(Aryl)‐N‐ und C(Aryl)‐S‐Verknüpfungen

2003 526 citations Steven V. Ley, Andrew W. Thomas Angewandte Chemie profile →

Peers

Countries citing papers authored by Andrew W. Thomas

Since Specialization

Citations

This map shows the geographic impact of Andrew W. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew W. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew W. Thomas more than expected).

Fields of papers citing papers by Andrew W. Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew W. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew W. Thomas. The network helps show where Andrew W. Thomas may publish in the future.

Co-authorship network of co-authors of Andrew W. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew W. Thomas. A scholar is included among the top collaborators of Andrew W. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew W. Thomas. Andrew W. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Basmisanil, a highly selective GABAA-α5 negative allosteric modulator: preclinical pharmacology and demonstration of functional target engagement in man 2021 ·Scientific Reports ·Joerg F. Hipp, Frédéric Knoflach, Robert A. Comley, Theresa M. Ballard, Michael Honer, Gerhard Trube, Rodolfo Gasser, Eric Prinssen, Tanya L. Wallace, Andreas Rothfuß, Henner Knust, (unknown), Michael Derks, Darren Bentley, Lisa Squassante, Stephane Navé, (unknown), Christoph Wandel, Andrew W. Thomas, Maria‐Clemencia Hernandez	24
2	Positive Allosteric Modulation ofGABA_BReceptors Ameliorates Sensorimotor Gating in Rodent Models 2014 ·CNS Neuroscience & Therapeutics ·Roberto Frau, Valentina Bini, Giuliano Pillolla, Pari Malherbe, (unknown), Andrew W. Thomas, Paola Devoto, Marco Bortolato	11
3	Inhibition of alcohol self-administration by positive allosteric modulators of the GABAB receptor in rats: lack of tolerance and potentiation of baclofen 2014 ·Psychopharmacology ·Paola Maccioni, (unknown), Andrew W. Thomas, Pari Malherbe, Claudia Mugnaini, Federico Corelli, Kimberly A. Leite‐Morris, Gian Luigi Gessa, Giancarlo Colombo	30
4	Reducing GABA _A α5 Receptor-Mediated Inhibition Rescues Functional and Neuromorphological Deficits in a Mouse Model of Down Syndrome 2013 ·Journal of Neuroscience ·Carmen Martínez‐Cué, Paula Martínez, Noemı́ Rueda, Rebeca Vidal, Susana García-Cerro, Verónica Vidal, Andrea Corrales, Juan A. Montero, Ángel Pazos, Jesús Flórez, Rodolfo Gasser, Andrew W. Thomas, Michael Honer, Frédéric Knoflach, José Luís Trejo, Joseph G. Wettstein, Maria‐Clemencia Hernandez	122
5	Reduction of alcohol intake by the positive allosteric modulator of the GABAB receptor, rac-BHFF, in alcohol-preferring rats 2012 ·Alcohol ·Barbara Loi, Paola Maccioni, Carla Lobina, Mauro A.M. Carai, Gian Luigi Gessa, Andrew W. Thomas, Pari Malherbe, Giancarlo Colombo	32
6	The positive allosteric modulator of the GABAB receptor, rac-BHFF, suppresses alcohol self-administration 2010 ·Drug and Alcohol Dependence ·Paola Maccioni, Andrew W. Thomas, Mauro A.M. Carai, Gian Luigi Gessa, Pari Malherbe, Giancarlo Colombo	43
7	The discovery and unique pharmacological profile of RO4938581 and RO4882224 as potent and selective GABAA α5 inverse agonists for the treatment of cognitive dysfunction 2009 ·Bioorganic & Medicinal Chemistry Letters ·Henner Knust, (unknown), Theresa M. Ballard, Bernd Buettelmann, Rodolfo Gasser, Holger Fischer, Maria‐Clemencia Hernandez, Frédéric Knoflach, (unknown), Heinz Stadler, Andrew W. Thomas, Gerhard Trube, (unknown)	55
8	Discovery of benzoylpiperazines as a novel class of potent and selective GlyT1 inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Emmanuel Pinard, Daniela Alberati, Edilio Borroni, Holger Fischer, Dominik Hainzl, Synèse Jolidon, Jean‐Luc Moreau, Robert Narquizian, Matthias Nettekoven, Roger D. Norcross, Henri Stalder, Andrew W. Thomas	18
9	RO4938581, a novel cognitive enhancer acting at GABAA α5 subunit-containing receptors 2008 ·Psychopharmacology ·Theresa M. Ballard, Frédéric Knoflach, Eric Prinssen, Edilio Borroni, Jeffrey A. Vivian, (unknown), Rodolfo Gasser, Jean‐Luc Moreau, Joseph G. Wettstein, Bernd Buettelmann, Henner Knust, Andrew W. Thomas, Gerhard Trube, Maria‐Clemencia Hernandez	129
10	Characterization of (R,S)‐5,7‐di‐tert‐butyl‐3‐hydroxy‐3‐trifluoromethyl‐3H‐benzofuran‐2‐one as a positive allosteric modulator of GABA_Breceptors 2008 ·British Journal of Pharmacology ·Pari Malherbe, Raffaello Masciadri, Roger D. Norcross, Frédéric Knoflach, Claudia Kratzeisen, (unknown), (unknown), Anne Marcuz, Jörg Huwyler, (unknown), Richard H. Porter, Andrew W. Thomas, Joseph G. Wettstein, Andrew J. Sleight, Will Spooren, E. Prinssen	85
11	Design and synthesis of 4-substituted-8-(2-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-one as a novel class of GlyT1 inhibitors: Achieving selectivity against the μ opioid and nociceptin/orphanin FQ peptide (NOP) receptors 2006 ·Bioorganic & Medicinal Chemistry Letters ·Daniela Alberati, Simona Ceccarelli, Synèse Jolidon, (unknown), (unknown), (unknown), Emmanuel Pinard, Henri Stalder, Deborah Studer, Andrew W. Thomas, Daniel Zimmerli	11
12	4-Substituted-8-(1-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-one as a novel class of highly selective GlyT1 inhibitors with superior pharmacological and pharmacokinetic parameters 2006 ·Bioorganic & Medicinal Chemistry Letters ·Daniela Alberati, Dominik Hainzl, Synèse Jolidon, (unknown), Emmanuel Pinard, Andrew W. Thomas, Daniel Zimmerli	7
13	An improved synthesis of Lu AA20465 2006 ·Tetrahedron Letters ·(unknown), Emmanuel Pinard, Andrew W. Thomas	3
14	Discovery of 4-substituted-8-(2-hydroxy-2-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-one as a novel class of highly selective GlyT1 inhibitors with improved metabolic stability 2006 ·Bioorganic & Medicinal Chemistry Letters ·Daniela Alberati, Dominik Hainzl, Synèse Jolidon, (unknown), (unknown), (unknown), Emmanuel Pinard, Andrew W. Thomas, Daniel Zimmerli	15
15	Lead Generation - Enhancing the Success of Drug Discovery by Investing in the Hit to Lead Process 2003 ·Combinatorial Chemistry & High Throughput Screening ·Alexander Alanine, Matthias Nettekoven, Edward Roberts, Andrew W. Thomas	38
16	Moderne Synthesemethoden: Kupfer‐vermittelte C(Aryl)‐O‐, C(Aryl)‐N‐ und C(Aryl)‐S‐Verknüpfungen breakdown → 2003 ·Angewandte Chemie ·Steven V. Ley, Andrew W. Thomas	526
17	A concise route to triazolobenzodiazepine derivatives via a one-Pot alkyne-Azide cycloaddition reaction 2002 ·Bioorganic & Medicinal Chemistry Letters ·Andrew W. Thomas	40
18	Accelerating Drug Discovery by Integrative Implementation of Laboratory Automation in the Work Flow 2002 ·Current Medicinal Chemistry ·Matthias Nettekoven, Andrew W. Thomas	16
19	Sigmoidorectal Intussusception from a Sigmoid Lipoma 1995 ·Journal of Clinical Gastroenterology ·Andrew W. Thomas, (unknown), G.J. Brodmerkel	10
20	Acute Pancreatitis as a Complication of Colonoscopy 1994 ·Journal of Clinical Gastroenterology ·Andrew W. Thomas, (unknown)	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact